Reprogramming of T Cells to Natural Killer–Like Cells upon <i>Bcl11b</i> Deletion
Peng Li(Chinese Academy of Sciences), Pentao Liu(Hong Kong Science and Technology Parks Corporation), Xiongfeng Chen(Science Applications International Corporation (United States)), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute), David Goulding(University of Limerick), Francesco Colucci(University of Cambridge), Dong Lu(Baylor College of Medicine), Lia S. Campos(Universidade Federal de Minas Gerais), Shannon Burke(Babraham Institute), Nancy A. Jenkins(The University of Texas MD Anderson Cancer Center), Mariaestela Ortiz(Science Applications International Corporation (United States)), Neal G. Copeland(The University of Texas MD Anderson Cancer Center), Song-Choon Lee(Wellcome Sanger Institute), Bee Ling Ng(Wellcome Sanger Institute), Gordon Dougan(University of Cambridge), Juexuan Wang(Wellcome Sanger Institute)
Cited by 358
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k